Dry Eye Syndrome
Showing NaN - NaN of 8
Dry Eye Syndrome Trial in Seoul (SA001 Low dose, SA001 Mid dose, SA001 High dose)
Completed
- Dry Eye Syndrome
- SA001 Low dose
- +3 more
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 4, 2022
Dry Eye Syndrome Trial in Seoul (TJO-087, Cyclosporine ophthalmic solution 0.05%)
Recruiting
- Dry Eye Syndrome
- TJO-087
- Cyclosporine ophthalmic solution 0.05%
-
Seoul, Korea, Republic ofHyo Myung, Kim
Feb 8, 2022
Dry Eye Syndrome Trial in Seoul (HU007, Restasis, Moisview)
Completed
- Dry Eye Syndrome
- HU007
- +2 more
-
Seoul, Korea, Republic ofSeoul ST.Mary's Hospital
May 6, 2020
Dry Eye Syndrome Trial in Seoul, Gyeonggi-do, Gwangju (KL7016 900mg, KL7016 600mg, Placebo)
Completed
- Dry Eye Syndrome
- KL7016 900mg
- +2 more
-
Seoul, Banpo-daero, Seocho-gu, Korea, Republic of
- +8 more
Dec 19, 2017
Influencing Factors on Dry Eye Syndrome and Ocular Surface
Completed
- Dry Eye Syndrome
- Ocular Surface Disease
- Observation
-
Seoul, Korea, Republic ofKangnam Sacred Heart Hospital
Dec 5, 2017
Factors Affecting the Tear-film Lipid Layer Thickness
Completed
- Dry Eye Syndrome
-
Seoul, Korea, Republic ofDepartment of Ophthalmology, Yonsei Univeristy College of Medici
Jan 24, 2017
Dry Eye Syndrome Trial in Korea, Republic of (Xenobella, Isotonic 0.3% Sodium Hyaluronate)
Unknown status
- Dry Eye Syndrome
- Xenobella
- Isotonic 0.3% Sodium Hyaluronate
-
Daejeon, Chungcheongnam-do, Korea, Republic of
- +13 more
May 17, 2016
Dry Eye Syndrome Trial in Seoul (DA-6034 3%, DA-6034 5%, DA-6034 Placebo)
Completed
- Dry Eye Syndrome
- DA-6034 3%
- +2 more
-
Seoul, Korea, Republic ofSeoul St.Mary's hospital
Sep 29, 2014